Kevin Weinstein, Frank Cockerill

Analyte Health has appointed Kevin Weinstein as CEO and Frank Cockerill as chief medical officer. Weinstein will also join the company's board of directors. He joins Analyte from Valence Health where served as the chief growth officer. Weinstein has also held various executive positions with ZirMed, Rise Health, and Allscripts. Cockerill will continue to serve on the company's board of directors.